About Halcyon Biomedical
Halcyon Biomedical is a company based in Friendswood (United States) founded in 2013. Halcyon Biomedical offers products and services including Lymphocyte Isolation, Large Cell Enrichment, and WBC Isolation. Halcyon Biomedical operates in a competitive market with competitors including Hemex Health, BioMedomics, ShanMukha Innovations, Silver Lake Research Corporation and HemaCore, among others.
- Headquarter Friendswood, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Halcyon Biomedical Incorporated
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$749.4 K (USD), Grant
May 01, 2020
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Halcyon Biomedical
Halcyon Biomedical offers a comprehensive portfolio of products and services, including Lymphocyte Isolation, Large Cell Enrichment, and WBC Isolation.
Service for isolating lymphocytes from whole blood samples
Process for enriching monocytes and CTC from undiluted blood
Method for isolating white blood cells from leukopaks
Funding Insights of Halcyon Biomedical
Investors in Halcyon Biomedical
Halcyon Biomedical has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and America’s Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Halcyon Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Halcyon Biomedical
Investment portfolio details for Halcyon Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Halcyon Biomedical
Detailed financials for Halcyon Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Halcyon Biomedical Comparisons
Peer comparison for Halcyon Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Halcyon Biomedical
Halcyon Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemex Health, BioMedomics, ShanMukha Innovations, Silver Lake Research Corporation and HemaCore, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platform providing care devices for the detection of tropical diseases
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic systems for blood-based disorders are developed.
|
|
| Locked | Locked | Locked |
Affordable point-of-care diagnostic solutions are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Custom antibodies and diagnostics are developed for various applications.
|
|
| Locked | Locked | Locked |
Instruments and assays for blood disorders are provided.
|
Detailed competitors of Halcyon Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Halcyon Biomedical
Complete news archive for Halcyon Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Halcyon Biomedical
Halcyon Biomedical was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Halcyon Biomedical is headquartered in Friendswood, United States. It is registered at Friendswood, Texas, United States.
Halcyon Biomedical develops diagnostic solutions for hematological disorders. Its flagship product utilizes differences in blood spread between normal blood and blood from a patient with sickle cell anemia, as seen on a chromatography paper, to diagnose the disease. In addition, the company is also developing a portable whole blood separator, a microfluidic device that enables separation of leukocytes from platelet-rich plasma, a lab-on-chip device for the selective enrichment of cell types in whole blood, a cell sorter focused on circulating tumor cells, and a platform for the enrichment of exosomes.
Halcyon Biomedical's top competitors include Hemex Health, Silver Lake Research Corporation and BioMedomics.
Halcyon Biomedical offers Lymphocyte Isolation, Large Cell Enrichment, and WBC Isolation.
Halcyon Biomedical has 2 investors. Key investors include HHS, and America’s Seed Fund.